AAMC
ABBV icon

Asset Allocation & Management Company’s AbbVie ABBV Stock Holding History

Asset Allocation & Management Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-948
Closed -$206K – 68
2026
Q1 		$206K Hold
948
– – 0.08% 94
2025
Q4 		$217K Hold
948
– – 0.09% 90
2025
Q3 		$219K Buy
+948
New +$193K 0.09% 87

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Asset Allocation & Management Company's ABBV Position: Q2 2026 in Review

Asset Allocation & Management Company sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 948 shares — an estimated $206K sold.

Asset Allocation & Management Company first reported a position in ABBV in Q3 2025 and held it in 3 quarters. The position peaked at $219K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Asset Allocation & Management Company reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Asset Allocation & Management Company sold 948 AbbVie shares in Q2 2026, an estimated $206K.
  • Asset Allocation & Management Company first reported a position in AbbVie in Q3 2025 and held it in 3 quarters.
  • Asset Allocation & Management Company's AbbVie position peaked at $219K in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Asset Allocation & Management Company's 13F filing for Q2 2026, filed 15 Jul 2026.